2012 annual financial data
Celldex Therapeutics 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -444.4%.
Operating income was -58,077,000 USD and net income was -59,123,000 USD.
Operating cash flow was -49,782,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 11,202,000 USD
- Operating income
- -58,077,000 USD
- Net income
- -59,123,000 USD
- Operating cash flow
- -49,782,000 USD